Effects of topical travoprost and unoprostone on optic nerve head circulation in normal rabbits

Current Eye Research

Volumn 32, Issue 9, 2007, Pages 743-749

  Ohashi, Masaaki ^a   Mayama, Chihiro ^b   Ishii, Kiyoshi ^b   Araie, Makoto ^b  

^a TORANOMON HOSPITAL   (Japan)

^b Tokyo Metropolitan Institute of Gerontology   (Japan)

Author keywords

Blood velocity; Optic nerve head; Travoprost; Unoprostone

Indexed keywords

INDOMETACIN; TRAVOPROST; UNOPROSTONE ISOPROPYL ESTER;

ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFECT; INTRAOCULAR PRESSURE; LASER; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; PULSE RATE; RABBIT; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, TOPICAL; ANIMALS; BLOOD FLOW VELOCITY; CLOPROSTENOL; DINOPROST; DRUG ADMINISTRATION SCHEDULE; INSTILLATION, DRUG; OPTIC DISK; RABBITS; REFERENCE VALUES; TIME FACTORS;

EID: 34548854559     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680701531090     Document Type: Article

References (44)

1. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull World Health Organ. 1995;73(1):115-121.
2. Foster A, Johnson G. Blindness in the developing world. Br J Ophthalmol. 1993;77(7):398-399.
3. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80(5):389-393.
4. Iwase A, Suzuki Y, Araie M, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology. 2004;111(9):1641-1648.
5. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262-267.
6. Bonomi L, Marchini G, Marraffa M, et al. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology. 2000;107(7):1287-1293.
7. Cioffi GA, Sullivan P. The effect of chronic ischemia on the primate optic nerve. Eur J Ophthalmol. 1999;9 (Suppl 1):S34-S36.
8. Fuchsjager-Mayrl G, Wally B, Georgopoulos M, et al. Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci. 2004;45(3):834-839.
9. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 1994;117(5):603-624.
10. Satilmis M, Orgul S, Doubler B, Flammer J. Rate of progression of glaucoma correlates with retrobulbar circulation and intraocular pressure. Am J Ophthalmol. 2003;135(5):664-669.
11. Kondo Y, Niwa Y, Yamamoto T, et al. Retrobulbar hemodynamics in normal-tension glaucoma with asymmetric visual field change and asymmetric ocular perfusion pressure. Am J Ophthalmol. 2000;130(4):454-460.
12. Ishii K, Tomidokoro A, Nagahara M, et al. Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans. Invest Ophthalmol Vis Sci. 2001;42(12):2957-2963.
13. Sponsel WE, Mensah J, Kiel JW, et al. Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye. Am J Ophthalmol. 2000;130(2):151-159.
14. Geyer O, Man O, Weintraub M, Silver DM. Acute effect of latanoprost on pulsatile ocular blood flow in normal eyes. Am J Ophthalmol. 2001;131(2):198-202.
15. Tamaki Y, Nagahara M, Araie M, et al. Topical latanoprost and optic nerve head and retinal circulation in humans. J Ocul Pharmacol Ther. 2001;17(5):403-411.
16. Poinoosawmy D, Indar A, Bunce C, et al. Effect of treatment by medicine or surgery on intraocular pressure and pulsatile ocular blood flow in normal-pressure glaucoma. Graefes Arch Clin Exp Ophthalmol. 2002;240(9):721-726.
17. Sponsel WE, Paris G, Trigo Y, Pena M. Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma. Am J Ophthalmol. 2002;134(4):552-9.
18. McKibbin M, Menage MJ. The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma. Eye. 1999;13( Pt 1):31-34.
19. Sharif NA, Davis TL, Williams GW. [3H]AL-5848 ([3H]9beta-(+)- Fluprostenol). Carboxylic acid of travoprost (AL-6221), a novel FP prostaglandin to study the pharmacology and autoradiographic localization of the FP receptor. J Pharm Pharmacol. 1999;51(6):685-694.
20. Hellberg MR, Sallee VL, McLaughlin MA, et al. Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist. J Ocul Pharmacol Ther. 2001;17(5):421-432.
21. Parrish RK, Palmberg P, Sheu WP. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol. 2003;135(5):688-703.
22. Przydryga JT, Egloff C. Intraocular pressure lowering efficacy of travoprost. Eur J Ophthalmol. 2004;14(5):416-422.
23. Sharif NA, Kelly CR, Crider JY. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor. J Ocul Pharmacol Ther. 2002;18(4):313-324.
24. Ota T, Aihara M, Narumiya S, Araie M. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice. Invest Ophthalmol Vis Sci. 2005;46(11):4159-4163.
25. Inan UU, Ermis SS, Orman A, et al. The comparative cardiovascular, pulmonary, ocular blood flow, and ocular hypotensive effects of topical travoprost, bimatoprost, brimonidine, and betaxolol. J Ocul Pharmacol Ther. 2004;20(4):293-310.
26. Makimoto Y, Sugiyama T, Kojima S, Azuma I. Long-term effect of topically applied isopropyl unoprostone on microcirculation in the human ocular fundus. Jpn J Ophthalmol. 2002;46(1):31-35.
27. Tamaki Y, Araie M, Tomita K, et al. Effect of topical unoprostone on circulation of human optic nerve head and retina. J Ocul Pharmacol Ther. 2001;17(6):517-527.
28. Briers JD, Fercher AF. Retinal blood-flow visualization by means of laser speckle photography. Invest Ophthalmol Vis Sci. 1982;22(2):255-259.
29. Tamaki Y, Araie M, Kawamoto E, et al. Non-contact, two-dimensional measurement of tissue circulation in choroid and optic nerve head using laser speckle phenomenon. Exp Eye Res. 1995;60(4):373-383.
30. Tomita K, Araie M, Tamaki Y, et al. Effects of nilvadipine, a calcium antagonist, on rabbit ocular circulation and optic nerve head circulation in NTG subjects. Invest Ophthalmol Vis Sci. 1999;40(6):1144-1151.
31. Takayama J, Tomidokoro A, Ishii K, et al. Time course of the change in optic nerve head circulation after an acute increase in intraocular pressure. Invest Ophthalmol Vis Sci. 2003;44(9):3977-3985.
32. Takayama J, Tomidokoro A, Tamaki Y, Araie M. Time course of changes in optic nerve head circulation after acute reduction in intraocular pressure. Invest Ophthalmol Vis Sci. 2005;46(4):1409-1419.
33. Tamaki Y, Araie M, Tomita K, Tomidokoro A. Time change of nicardipine effect on choroidal circulation in rabbit eyes. Curr Eye Res. 1996;15(5):543-548.
34. Tamaki Y, Araie M, Kawamoto E, et al. Noncontact, two-dimensional measurement of retinal microcirculation using laser speckle phenomenon. Invest Ophthalmol Vis Sci. 1994;35(11):3825-3834.
35. Tomidokoro A, Araie M, Tamaki Y, Tomita K. In vivo measurement of iridial circulation using laser speckle phenomenon. Invest Ophthalmol Vis Sci. 1998;39(2):364-371.
36. Sugiyama T, Utsumi T, Azuma I, Fujii H. Measurement of optic nerve head circulation: comparison of laser speckle and hydrogen clearance methods. Jpn J Ophthalmol. 1996;40(3):339-343.
37. Ishii K, Matsuo H, Fukaya Y, et al. Iganidipine, a new water-soluble Ca2+ antagonist: ocular and periocular penetration after instillation. Invest Ophthalmol Vis Sci. 2003;44(3):1169-1177.
38. Mizuno K, Koide T, Saito N, et al. Topical nipradilol: effects on optic nerve head circulation in humans and periocular distribution in monkeys. Invest Ophthalmol Vis Sci. 2002;43(10):3243-3250.
39. Taniguchi T, Haque MS, Sugiyama K, et al. Ocular hypotensive mechanism of topical isopropyl unoprostone, a novel prostaglandin metabolite-related drug, in rabbits. J Ocul Pharmacol Ther. 1996;12(4):489-498.
40. Sugiyama T, Azuma I. Effect of UF-021 on optic nerve head circulation in rabbits. Jpn J Ophthalmol. 1995;39(2):124-129.
41. Ota T, Aihara M, Saeki T, et al. The effects of prostaglandin analogues on prostanoid EP1, EP2, and EP3 receptor-deficient mice. Invest Ophthalmol Vis Sci. 2006;47(8):3395-3399.
42. Wu KY, Wang HZ, Hong SJ. Inhibition of endothelin-1 and KCL-induced increase of [CA2+]i by antiglaucoma drugs in cultured A7r5 vascular smooth-muscle cells. J Ocul Pharmacol Ther. 2004;20(3):201-209.
43. Thieme H, Steinhausen K, Ottlecz A, et al. Effects of unoprostone and endothelin 1 on L-type channel currents in human trabecular meshwork cells. Ophthalmic Res. 2005;37(6):293-300.
44. Yoshitomi T, Yamaji K, Ishikawa H, Ohnishi Y. Vasodilatory mechanism of unoprostone isopropyl on isolated rabbit ciliary artery. Curr Eye Res. 2004;28(3):167-174.